TY - JOUR
T1 - 13th St. Gallen international breast cancer conference 2013: Primary therapy of early breast cancer evidence, controversies, consensus - Opinion of a German team of experts (Zurich 2013)
AU - Untch, Michael
AU - Gerber, Bernd
AU - Harbeck, Nadia
AU - Jackisch, Christian
AU - Marschner, Norbert
AU - Möbus, Volker
AU - Von Minckwitz, Gunter
AU - Loibl, Sibylle
AU - Beckmann, Matthias W.
AU - Blohmer, Jens Uwe
AU - Costa, Serban Dan
AU - Decker, Thomas
AU - Diel, Ingo
AU - Dimpfl, Thomas
AU - Eiermann, Wolfgang
AU - Fehm, Tanja
AU - Friese, Klaus
AU - Jänicke, Fritz
AU - Janni, Wolfgang
AU - Jonat, Walter
AU - Kiechle, Marion
AU - Köhler, Uwe
AU - Lück, Hans Joachim
AU - Maass, Nicolai
AU - Possinger, Kurt
AU - Rody, Achim
AU - Scharl, Anton
AU - Schneeweiss, Andreas
AU - Thomssen, Christoph
AU - Wallwiener, Diethelm
AU - Welt, Anja
PY - 2013/6/1
Y1 - 2013/6/1
N2 - The International Consensus Conference on the treatment of primary breast cancer takes place every two years in St. Gallen, Switzerland. The panel in St. Gallen is composed of international experts from different countries. From a German perspective, it seems reasonable to interpret the voting results in the light of AGO-recommendations and S3-guidelines for everyday practice in Germany. Consequently, a team of eight breast cancer experts, of whom two are members of the international St. Gallen panel, commented on the voting results of the St. Gallen Consensus Conference (2013). The main topics at this year's St. Gallen conference were surgical issues of the breast and axilla, radio-therapeutic and systemic treatment options, and the clinical relevance of tumour biology. The clinical utility of multigene assays for supporting individual treatment decisions was also intensively discussed.
AB - The International Consensus Conference on the treatment of primary breast cancer takes place every two years in St. Gallen, Switzerland. The panel in St. Gallen is composed of international experts from different countries. From a German perspective, it seems reasonable to interpret the voting results in the light of AGO-recommendations and S3-guidelines for everyday practice in Germany. Consequently, a team of eight breast cancer experts, of whom two are members of the international St. Gallen panel, commented on the voting results of the St. Gallen Consensus Conference (2013). The main topics at this year's St. Gallen conference were surgical issues of the breast and axilla, radio-therapeutic and systemic treatment options, and the clinical relevance of tumour biology. The clinical utility of multigene assays for supporting individual treatment decisions was also intensively discussed.
UR - http://www.scopus.com/inward/record.url?scp=84880741094&partnerID=8YFLogxK
U2 - 10.1159/000351692
DO - 10.1159/000351692
M3 - Journal articles
AN - SCOPUS:84880741094
SN - 1661-3791
VL - 8
SP - 221
EP - 229
JO - Breast Care
JF - Breast Care
IS - 3
ER -
